Mar 21 2024 31 mins
Cancer is not an easy topic to discuss. It is a devastating disease that takes over 10 million lives a year—600 thousand of those in the U.S. alone. To anyone who has gone through it or has loved ones who have fought cancer, it helps to know that you are not alone in that fight. Hundreds of organizations around the globe are focused on researching cancer from different angle—in the hopes of helping people through all stages of the process. One of those organizations working on discovering easier and less intensive ways to detect cancer is Guardant Health. They are a precision oncology company focused on reducing those numbers across all stages—from screening to find cancer and monitoring for recurrences in early-stages to helping doctors select treatments for patients with more advanced-stages. The half a billion-dollar public company has been making strides in cancer screening accuracy and accessibility through blood tests versus biopsies. We invited the Co-Founder and Co-CEO of Guardant Health, AmirAli Talasaz, for an episode of The Reboot Chronicles, to unpack how their simple blood tests could be the best and easiest way to fight the war on cancer.
--- Send in a voice message: https://podcasters.spotify.com/pod/show/rebootchronicles/message